Molecular imaging has a powerful new weapon in the fight against prostate cancer. Research demonstrates how a novel peptide-targeted imaging agent could help clinicians detect a biological process that signals cancer in prostate cells. Information gathered about this process may even differentiate prostate tumor types and the progression of disease.